Welcome to ResMed.com
This area of our site caters to hospital-based doctors, nurses and purchasing officers.
ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.
ResMed changes lives by developing, manufacturing and distributing innovative medical devices and cloud-based software solutions to better diagnose, treat, and manage sleep-disordered breathing, COPD, and other key chronic diseases.
When ResMed was formed in 1989, our primary purpose was to commercialize a device for treating obstructive sleep apnea (OSA), a major subset of sleep-disordered breathing (SDB).
Our Vision is to be the global solutions leader for SDB, COPD and other major chronic diseases. Our Mission is to improve the quality of life for patients, prevent progression of chronic diseases, and reduce overall healthcare system costs.
ResMed’s executive team is committed to the highest standards of ethics and professional integrity, translating to great partnerships with our customers, our suppliers, and with our global ResMed team.